{
    "output": [
        [
            "Alder Biopharmaceuticals Inc",
            "COMP",
            "Enter into",
            "European Patent Settlement",
            "EVENT"
        ],
        [
            "Alder Biopharmaceuticals Inc",
            "COMP",
            "Global License Agreement",
            "Teva",
            "ORG"
        ],
        [
            "Alder Biopharmaceuticals Inc",
            "COMP",
            "Make one-time payment",
            "$25 Million",
            "ECON_INDICATOR"
        ],
        [
            "Alder Biopharmaceuticals Inc",
            "COMP",
            "Withdraw appeal",
            "European Patent Office",
            "ORG/REG"
        ],
        [
            "Alder Biopharmaceuticals Inc",
            "COMP",
            "Pay",
            "$75 Million",
            "ECON_INDICATOR"
        ],
        [
            "Alder Biopharmaceuticals Inc",
            "COMP",
            "Provide royalty payments",
            "Net Sales",
            "ECON_INDICATOR"
        ],
        [
            "Alder Biopharmaceuticals Inc",
            "COMP",
            "Make second one-time payment",
            "$25 Million",
            "ECON_INDICATOR"
        ],
        [
            "Alder Biopharmaceuticals Inc",
            "COMP",
            "Approval of BLA",
            "Eptinezumab",
            "PRODUCT"
        ],
        [
            "Alder Biopharmaceuticals Inc",
            "COMP",
            "Commercial Launch",
            "Eptinezumab",
            "PRODUCT"
        ],
        [
            "Teva",
            "ORG",
            "Global License Agreement",
            "Alder Biopharmaceuticals Inc",
            "COMP"
        ],
        [
            "Teva",
            "ORG",
            "Receive one-time payment",
            "$25 Million",
            "ECON_INDICATOR"
        ],
        [
            "Teva",
            "ORG",
            "Receive royalty payments",
            "Net Sales",
            "ECON_INDICATOR"
        ],
        [
            "Teva",
            "ORG",
            "Receive second one-time payment",
            "$25 Million",
            "ECON_INDICATOR"
        ],
        [
            "Eptinezumab",
            "PRODUCT",
            "Commercial Launch",
            "Alder Biopharmaceuticals Inc",
            "COMP"
        ],
        [
            "Eptinezumab",
            "PRODUCT",
            "Approval of BLA",
            "Alder Biopharmaceuticals Inc",
            "COMP"
        ],
        [
            "Net Sales",
            "ECON_INDICATOR",
            "Provide royalty payments",
            "Alder Biopharmaceuticals Inc",
            "COMP"
        ],
        [
            "Net Sales",
            "ECON_INDICATOR",
            "Receive royalty payments",
            "Teva",
            "ORG"
        ]
    ]
}